Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ElechtraPlatinum: Electrochemotherapy with Carboplatin plus Bleomycin versus Bleomycin alone in Vulvar Cancer
2024-518370-14-00Phase 2Authorised
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Nov 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Vulval carcinoma comparing Bleomycin electrochemotherapy with Carboplatin plus bleomycin electrochemotherapy (2 arms). Primary endpoint: local progression free survival. Planned start Nov 2024; status: authorised.
02
Drugs
bleomycincarboplatin
03
Conditions
Vulval carcinoma
Beyond the preview
Go deeper on 2024-518370-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518370-14-00.